Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

United Arab Emirates · Delayed Price · Currency is AED

1.050

+0.020 (1.94%)

At close: Aug 13, 2026

-26.57% (1Y)

Market Cap	1.19B -28.0%
Revenue (ttm)	1.07B +13.8%
Net Income	81.40M -51.7%
EPS	0.07 -51.7%
Shares Out	1.16B
PE Ratio	17.10
Forward PE	12.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,132,420
Open	1.040
Previous Close	1.030
Day's Range	1.040 - 1.060
52-Week Range	0.956 - 1.490
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About ADX:JULPHAR

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wo... [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Employees 2,400

Stock Exchange Abu Dhabi Securities Exchange

Ticker Symbol JULPHAR

Full Company Profile

Financial Performance

In 2025, ADX:JULPHAR's revenue was 1.08 billion, an increase of 8.40% compared to the previous year's 992.20 million. Earnings were 172.20 million, an increase of 286.10%.

Financial Statements